BRIEF published on 10/02/2024 at 16:40, 1 month 20 days ago Cherry SE Misses Revenue Forecast for Q3 2024 due to Weak German Market Revenue Forecast Cherry SE German Market Q3 2024 Cost Reductions
BRIEF published on 10/02/2024 at 16:35, 1 month 20 days ago Restructuring of Cherry SE's Gaming & Office Peripherals Division Cherry SE Restructuring European Markets CEO Oliver Kaltner Gaming & Office Peripherals
PRESS RELEASE published on 10/02/2024 at 16:35, 1 month 20 days ago Cherry SE misses revenue forecast for the third quarter of 2024 due to weak German market Cherry SE misses Q3 revenue forecast due to weak German market conditions, anticipates EUR 22 million revenue. Cost cuts and review of 2024 forecast ongoing Revenue Forecast Cherry SE Germany Q3 Cost Cuts
PRESS RELEASE published on 10/02/2024 at 16:30, 1 month 20 days ago Restructuring of the Gaming & Office Peripherals division Cherry SE announces restructuring of Gaming & Office Peripherals division. CEO takes over interim management, realignment of sales organization Cherry SE Restructuring CEO Sales Organization Gaming & Office Peripherals
BRIEF published on 10/02/2024 at 16:28, 1 month 20 days ago Cherry SE Misses Q3 2024 Sales Forecast Adjusted EBITDA Cherry SE Revenue Miss Q3 2024 Sales Forecast
PRESS RELEASE published on 10/02/2024 at 16:23, 1 month 20 days ago EQS-Adhoc: Cherry SE: Forecast miss Q3/2024 Cherry SE misses Q3/2024 sales forecast leading to a profit warning due to lower consolidated revenue, impacting EBITDA margin. Management Board assessing impact EBITDA Margin Cherry SE Management Board Sales Forecast Profit Warning
BRIEF published on 09/17/2024 at 16:35, 2 months 5 days ago Cherry SE: SmartLink Product Approval is Imminent Cherry SE Saas SmartLink Product Approval Healthcare Digitalization
PRESS RELEASE published on 09/17/2024 at 16:30, 2 months 5 days ago Cherry SE: SmartLink product approval is imminent Cherry SE anticipates imminent approval for its CHERRY SmartLink product, a new eHealth card terminal software solution, aiming to revolutionize healthcare digitalization Healthcare Cherry SE Digitalization SmartLink Product Approval
BRIEF published on 08/06/2024 at 08:36, 3 months 17 days ago Cherry SE Releases 2024 Half-Year Report Adjusted EBITDA Revenue Growth Half-year Report Cherry SE 2024 Forecast
PRESS RELEASE published on 08/06/2024 at 08:31, 3 months 17 days ago Cherry SE Releases 2024 Half-Year Report Cherry SE releases its 2024 Half-Year Report, showing revenue growth in DIGITAL HEALTH & SOLUTIONS segment and confirmed forecasts for 2024 Revenue Growth Cherry SE Forecasts 2024 Half-Year Report DIGITAL HEALTH & SOLUTIONS
Published on 11/22/2024 at 23:55, 10 hours 41 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 6 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 11 hours 31 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 6 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 16 hours 21 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 16 hours 42 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 17 hours 40 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 18 hours 35 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 3 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 15 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 16 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 16 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
